L3VLUP
ProSign in

EXEL in the 13F filings

Exelixis Inc · CUSIP 30161Q104

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
30 Sep 2024
the date the book describes
Filed
14 Nov 2024
latest of these filings; the earliest 12 Nov 2024
Managers listing it
12
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q2 2024 and Q3 2024; 11 listed it in both
Shares listed
51,418,534
combined, among listed positions
Reported value
$1.3bn
combined, at the quarter end

Among the 94 comparable managers: 8 buyers (opened or added shares) and 4 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing EXEL in Q3 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

12 of 12 holders

ActionFiling
Farallon Capital Management LLC25,410,500$659m2.89%Trimmed-1,692,00014 Nov 2024 (the filing on sec.gov)
Renaissance Technologies LLC15,359,916$399m0.60%Added+196,85013 Nov 2024 (the filing on sec.gov)
AQR Capital Management LLC3,156,148$82m0.11%Trimmed-125,43014 Nov 2024 (the filing on sec.gov)
Acadian Asset Management LLC2,029,721$53m0.16%Added+1,571,86812 Nov 2024 (the filing on sec.gov)
Two Sigma Advisers LP1,702,590$44m0.10%Added+98,00014 Nov 2024 (the filing on sec.gov)
Arrowstreet Capital LP1,545,913$40munder 0.1%Added+348,41614 Nov 2024 (the filing on sec.gov)
Woodline Partners LP993,130$26m0.22%Added+6,03614 Nov 2024 (the filing on sec.gov)
Two Sigma Investments LP849,664$22munder 0.1%Addedn.a.14 Nov 2024 (the filing on sec.gov)
Winton Group Ltd268,853$7.0m0.49%Added+224,26912 Nov 2024 (the filing on sec.gov)
Brevan Howard Capital Management LP48,886$1.3munder 0.1%Trimmed-18,85514 Nov 2024 (the filing on sec.gov)
Caxton Associates LLP35,726$927kunder 0.1%Trimmed-37,22714 Nov 2024 (the filing on sec.gov)
First Eagle Investment Management LLC17,487$454kunder 0.1%Added+1,60012 Nov 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2024 to Q3 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
12 in Q3 2024 to 15 in Q2 2026

Tracked managers listing it, at least.

01020302014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
EXEL by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20134$200mn.a.n.a.
Q3 20134$267mn.a.n.a.
Q4 20133$283mn.a.n.a.
Q1 20144$3.6mn.a.n.a.
Q4 20141$3.5mn.a.n.a.
Q3 20151$138mn.a.n.a.
Q4 20154$185mn.a.n.a.
Q1 20161$905kn.a.n.a.
Q2 20167$108mn.a.n.a.
Q3 201612$909mn.a.n.a.
Q4 201614$1.3bnn.a.n.a.
Q1 201711$1.6bnn.a.n.a.
Q2 201721$1.9bnn.a.n.a.
Q3 201715$1.9bnn.a.n.a.
Q4 201715$2.2bnn.a.n.a.
Q1 201813$1.4bnn.a.n.a.
Q2 20189$902mn.a.n.a.
Q3 20187$619mn.a.n.a.
Q4 201810$818mn.a.n.a.
Q1 20197$1.2bnn.a.n.a.
Q2 20195$1.0bnn.a.n.a.
Q3 20197$533mn.a.n.a.
Q4 201910$659mn.a.n.a.
Q1 202012$924mn.a.n.a.
Q2 202018$1.5bnn.a.n.a.
Q3 202018$1.8bnn.a.n.a.
Q4 202011$1.2bnn.a.n.a.
Q1 202113$1.3bnn.a.n.a.
Q2 202110$976mn.a.n.a.
Q3 202113$1.1bnn.a.n.a.
Q4 20219$922mn.a.n.a.
Q1 202210$1.2bnn.a.n.a.
Q2 202212$1.4bnn.a.n.a.
Q3 202211$630mn.a.n.a.
Q4 202211$714mn.a.n.a.
Q1 202312$1.1bnn.a.n.a.
Q2 202310$976mn.a.n.a.
Q3 202312$1.1bnn.a.n.a.
Q4 202313$1.2bn66
Q1 202411$1.2bn64
Q2 202411$1.1bn73
Q3 202412$1.3bn84
Q4 202413$1.8bn76
Q1 202513$2.0bn75
Q2 202513$2.1bn68
Q3 20259$2.1bn54
Q4 202511$2.3bn1916
Q1 202612$2.3bn1420
Q2 202615$3.1bn2210

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

EXEL and GILD →EXEL and AMGN →EXEL and ARGX →Choose a stock to compare with EXEL →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own EXEL, latest filings →Back to the 13F Explorer →